Screener
Capricor Therapeutics CAPR PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| Line item | March 31, 2026 / (unaudited) | December 31, 2025 | December 31, 2025 |
|---|---|---|---|
| Receivables | — | 59,167 | |
| Prepaid expenses and other current assets | 4,478,895 | 4,751,674 | |
| TOTAL CURRENT ASSETS | 283,088,809 | 322,939,756 | |
| PROPERTY AND EQUIPMENT, net | 28,502,617 | 18,312,238 | |
| OTHER ASSETS | |||
| Lease right-of-use assets, net | 13,158,500 | 13,537,820 | |
| Other assets | 1,533,591 | 1,159,480 | |
| TOTAL ASSETS | $326,283,517 | $ | $355,949,294 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's PP&E (net)?
- Capricor Therapeutics (CAPR) reported PP&E (net) of $28.5M in Q1 2026.
- How has Capricor Therapeutics's PP&E (net) changed year-over-year?
- Capricor Therapeutics's PP&E (net) increased by 364.7% year-over-year, from $6.13M to $28.5M.
- What is the long-term trend for Capricor Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Capricor Therapeutics's PP&E (net) has grown at a 84.7% compound annual growth rate (CAGR), from $850.85K to $18.31M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Capricor Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude